Europlasma S.A. (EPA:ALEUP)
France · Delayed Price · Currency is EUR 0.0032
+0.0002 (6.67%)
Jun 22, 2026, 5:35 PM CET
Europlasma Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 59.8 | 42.45 | 15.41 | 14.52 | 9.8 | 3.8 |
Other Revenue | 0.34 | 0.37 | 0.04 | 0.37 | 1.43 | 2.79 |
| 60.14 | 42.82 | 15.44 | 14.89 | 11.24 | 6.59 | |
Revenue Growth (YoY) | 152.06% | 177.25% | 3.71% | 32.51% | 70.64% | 99.73% |
Cost of Revenue | 34.05 | 20.18 | 11.7 | 9.18 | 6.17 | 4.97 |
Gross Profit | 26.1 | 22.63 | 3.75 | 5.71 | 5.07 | 1.62 |
Selling, General & Admin | 45.83 | 34.23 | 17.89 | 17.57 | 14.54 | 11.39 |
Other Operating Expenses | -3.73 | 1.97 | -1.33 | -0.04 | -0.2 | 0.09 |
Operating Expenses | 54.04 | 48.93 | 23.39 | 21.71 | 16.55 | 12.37 |
Operating Income | -27.94 | -26.29 | -19.64 | -16 | -11.48 | -10.75 |
Interest Expense | -8.49 | -3.14 | -3.58 | -5.66 | -6.27 | -14.91 |
Interest & Investment Income | 0.03 | 0.01 | 0.04 | 0.01 | 0 | 0.01 |
Earnings From Equity Investments | - | - | - | - | -0.45 | - |
Currency Exchange Gain (Loss) | -0.22 | 0.01 | - | -0.01 | 0.07 | 0 |
Other Non Operating Income (Expenses) | -10.95 | 6.28 | 7.16 | -1.99 | 0.12 | -0.34 |
EBT Excluding Unusual Items | -47.58 | -23.14 | -16.02 | -23.65 | -18.02 | -25.99 |
Asset Writedown | 0.05 | 0.05 | -0.18 | -0.46 | -0.1 | -0.9 |
Other Unusual Items | -0.8 | 4.42 | 1.1 | 8.12 | 5.14 | 16.25 |
Pretax Income | -48.33 | -18.66 | -15.1 | -15.99 | -12.97 | -10.64 |
Income Tax Expense | -2.13 | -2.75 | -0.36 | -0.24 | -0.3 | - |
Earnings From Continuing Operations | -46.2 | -15.91 | -14.75 | -15.75 | -12.68 | -10.64 |
Minority Interest in Earnings | 1.72 | 0.62 | 0 | -0.17 | 0 | 0.76 |
Net Income | -44.48 | -15.29 | -14.74 | -15.92 | -12.67 | -9.88 |
Net Income to Common | -44.48 | -15.29 | -14.74 | -15.92 | -12.67 | -9.88 |
Free Cash Flow | -26.13 | -12.4 | -11.7 | -8.04 | -23.63 | -16.89 |
Gross Margin | 43.39% | 52.86% | 24.26% | 38.36% | 45.12% | 24.59% |
Operating Margin | -46.46% | -61.41% | -127.18% | -107.45% | -102.18% | -163.28% |
Profit Margin | -73.96% | -35.71% | -95.47% | -106.94% | -112.78% | -150.04% |
Free Cash Flow Margin | -43.45% | -28.96% | -75.76% | -54.01% | -210.32% | -256.43% |
EBITDA | -16.05 | -13.87 | -14.82 | -10.96 | -10.2 | -10.54 |
EBITDA Margin | -26.68% | -32.39% | -95.95% | -73.59% | -90.74% | -160.11% |
D&A For EBITDA | 11.9 | 12.42 | 4.82 | 5.04 | 1.29 | 0.21 |
EBIT | -27.94 | -26.29 | -19.64 | -16 | -11.48 | -10.75 |
EBIT Margin | -46.46% | -61.41% | -127.18% | -107.45% | -102.18% | -163.28% |